SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-308647
Filing Date
2019-12-09
Accepted
2019-12-09 06:43:34
Documents
5
Period of Report
2019-12-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d838663d8k.htm 8-K 36301
2 EX-2.1 d838663dex21.htm EX-2.1 403986
3 EX-99.1 d838663dex991.htm EX-99.1 26666
4 EX-99.2 d838663dex992.htm EX-99.2 14218
5 GRAPHIC g838663g42f32.jpg GRAPHIC 11866
  Complete submission text file 0001193125-19-308647.txt   498906
Mailing Address 11099 NORTH TORREY PINES ROAD SUITE 190 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD SUITE 190 LA JOLLA CA 92037 (858) 750-4700
Synthorx, Inc. (Filer) CIK: 0001609727 (see all company filings)

IRS No.: 464709185 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38756 | Film No.: 191274288
SIC: 2834 Pharmaceutical Preparations